Tsumura & Co. (TYO: 4540)
Japan
· Delayed Price · Currency is JPY
4,469.00
-42.00 (-0.93%)
Jan 20, 2025, 3:30 PM JST
Tsumura & Co. Revenue
Tsumura & Co. had revenue of 45.38B JPY in the quarter ending September 30, 2024, with 18.59% growth. This brings the company's revenue in the last twelve months to 164.61B, up 13.34% year-over-year. In the fiscal year ending March 31, 2024, Tsumura & Co. had annual revenue of 150.85B with 7.71% growth.
Revenue (ttm)
164.61B
Revenue Growth
+13.34%
P/S Ratio
2.06
Revenue / Employee
39.78M
Employees
4,138
Market Cap
339.34B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 150.85B | 10.80B | 7.71% |
Mar 31, 2023 | 140.04B | 10.50B | 8.10% |
Mar 31, 2022 | 129.55B | -1.34B | -1.02% |
Mar 31, 2021 | 130.88B | 7.64B | 6.19% |
Mar 31, 2020 | 123.25B | 2.34B | 1.94% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,142.35B |
Daiichi Sankyo Company | 1,758.07B |
HOYA Corporation | 812.74B |
Takeda Pharmaceutical Company | 4,546.08B |
Otsuka Holdings | 2,269.56B |
Terumo | 986.67B |
Astellas Pharma | 1,772.16B |
Olympus | 973.60B |